![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | A61P 35/00 | (2006.01) |
A61K 39/00 | (2006.01) | ||
C07K 16/28 | (2006.01) |
(11) | Number of the document | 3151921 |
(13) | Kind of document | T |
(96) | European patent application number | 15742414.4 |
Date of filing the European patent application | 2015-06-03 | |
(97) | Date of publication of the European application | 2017-04-12 |
(45) | Date of publication and mention of the grant of the patent | 2019-08-28 |
(46) | Date of publication of the claims translation | 2019-12-10 |
(86) | Number | PCT/US2015/033991 |
Date | 2015-06-03 |
(87) | Number | WO 2015/187835 |
Date | 2015-12-10 |
(30) | Number | Date | Country code |
201462008945 P | 2014-06-06 | US | |
201462082980 P | 2014-11-21 | US |
(72) |
WANG, Changyu, US
LONBERG, Nils, US
KORMAN, Alan J., US
SELBY, Mark J., US
SRINIVASAN, Mohan, US
HENNING, Karla, US
HAN, Michelle, Minhua, US
CHEN, Guodong, US
HUANG, Richard, US
CHAKRABORTY, Indrani, US
HUANG, Haichun, US
WONG, Susan, US
LI, Huiming, US
|
(73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
(74) |
Otilija KLIMAITIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Antikūnai prieš gliukokortikoidu indukuojamą naviko nekrozės faktoriaus receptorių (GITR) ir jų panaudojimas |
ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) AND USES THEREOF |
Payment date | Validity (years) | Amount | |
2023-05-29 | 9 | 208.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2024-06-03 |